HEADER NUCLEAR PROTEIN 23-MAR-11 3R8A TITLE X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN TITLE 2 A COMPLEX WITH A COMPOUND WITH DUAL PPAR GAMMA AGONISM AND TITLE 3 ANGIOTENSIN II TYPE I RECEPTOR ANTAGONISM ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1C3, PPARG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR HORMONE ACTIVATOR, ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST, KEYWDS 2 LIGAND BOUND STRUCTURE, DIABETES MELLITUS, METABOLIC SYNDROME, KEYWDS 3 OBESITY, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.F.OHREN REVDAT 2 13-SEP-23 3R8A 1 REMARK SEQADV REVDAT 1 14-MAR-12 3R8A 0 JRNL AUTH A.CASIMIRO-GARCIA,G.F.FILZEN,D.FLYNN,C.F.BIGGE,J.CHEN, JRNL AUTH 2 J.A.DAVIS,D.A.DUDLEY,J.J.EDMUNDS,N.ESMAEIL,A.GEYER, JRNL AUTH 3 R.J.HEEMSTRA,M.JALAIE,J.F.OHREN,R.OSTROSKI,T.ELLIS, JRNL AUTH 4 R.P.SCHAUM,C.STONER JRNL TITL DISCOVERY OF A SERIES OF IMIDAZO[4,5-B]PYRIDINES WITH DUAL JRNL TITL 2 ACTIVITY AT ANGIOTENSIN II TYPE 1 RECEPTOR AND PEROXISOME JRNL TITL 3 PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA. JRNL REF J.MED.CHEM. V. 54 4219 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21557540 JRNL DOI 10.1021/JM200409S REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 24537 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.250 REMARK 3 FREE R VALUE TEST SET COUNT : 1287 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.41 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.52 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2430 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 131 REMARK 3 BIN FREE R VALUE : 0.3138 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3912 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.51780 REMARK 3 B22 (A**2) : 0.29500 REMARK 3 B33 (A**2) : -1.81280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.13250 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3R8A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24537 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.410 REMARK 200 RESOLUTION RANGE LOW (A) : 37.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.41 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5 REMARK 200 STARTING MODEL: PDB ENTRY 3IA6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: APO CRYSTALS GROWN FROM REMARK 280 CITRATE/IMIDAZOLE, THEN SOAKED WITH 0.5 MM COMPOUND 2A, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.34850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.91550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.34850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.91550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 196 REMARK 465 LYS A 197 REMARK 465 LYS A 198 REMARK 465 GLY A 199 REMARK 465 HIS A 200 REMARK 465 HIS A 201 REMARK 465 HIS A 202 REMARK 465 HIS A 203 REMARK 465 HIS A 204 REMARK 465 HIS A 205 REMARK 465 GLY A 206 REMARK 465 THR A 241 REMARK 465 THR A 242 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 GLU A 471 REMARK 465 ILE A 472 REMARK 465 TYR A 473 REMARK 465 LYS A 474 REMARK 465 ASP A 475 REMARK 465 LEU A 476 REMARK 465 TYR A 477 REMARK 465 MET B 196 REMARK 465 LYS B 197 REMARK 465 LYS B 198 REMARK 465 GLY B 199 REMARK 465 HIS B 200 REMARK 465 HIS B 201 REMARK 465 HIS B 202 REMARK 465 HIS B 203 REMARK 465 HIS B 204 REMARK 465 HIS B 205 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 GLY B 258 REMARK 465 GLU B 259 REMARK 465 ASP B 260 REMARK 465 LYS B 261 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 ILE B 456 REMARK 465 LYS B 457 REMARK 465 LYS B 458 REMARK 465 THR B 459 REMARK 465 GLU B 460 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 260 44.08 -106.22 REMARK 500 LYS A 275 -74.62 -118.36 REMARK 500 PRO A 304 107.27 -60.00 REMARK 500 LEU A 393 49.41 -89.60 REMARK 500 ASP A 396 16.24 -157.53 REMARK 500 LEU A 401 -73.68 -65.56 REMARK 500 THR A 461 21.74 -70.41 REMARK 500 ASP A 462 -127.98 -79.04 REMARK 500 THR B 238 -78.21 -76.51 REMARK 500 SER B 342 53.37 39.15 REMARK 500 LEU B 393 47.74 -80.65 REMARK 500 GLN B 454 40.90 -78.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HIG A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HIG B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IA6 RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA REMARK 900 IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST REMARK 900 RELATED ID: 2Q8S RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA REMARK 900 IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST DBREF 3R8A A 207 477 UNP P37231 PPARG_HUMAN 235 505 DBREF 3R8A B 207 477 UNP P37231 PPARG_HUMAN 235 505 SEQADV 3R8A MET A 196 UNP P37231 EXPRESSION TAG SEQADV 3R8A LYS A 197 UNP P37231 EXPRESSION TAG SEQADV 3R8A LYS A 198 UNP P37231 EXPRESSION TAG SEQADV 3R8A GLY A 199 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 200 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 201 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 203 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 204 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS A 205 UNP P37231 EXPRESSION TAG SEQADV 3R8A GLY A 206 UNP P37231 EXPRESSION TAG SEQADV 3R8A MET B 196 UNP P37231 EXPRESSION TAG SEQADV 3R8A LYS B 197 UNP P37231 EXPRESSION TAG SEQADV 3R8A LYS B 198 UNP P37231 EXPRESSION TAG SEQADV 3R8A GLY B 199 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 200 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 201 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 202 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 203 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 204 UNP P37231 EXPRESSION TAG SEQADV 3R8A HIS B 205 UNP P37231 EXPRESSION TAG SEQADV 3R8A GLY B 206 UNP P37231 EXPRESSION TAG SEQRES 1 A 282 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLU SER SEQRES 2 A 282 ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SER SEQRES 3 A 282 TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA ARG SEQRES 4 A 282 ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO PHE SEQRES 5 A 282 VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU ASP SEQRES 6 A 282 LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SEQRES 7 A 282 SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN SEQRES 8 A 282 PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU TYR SEQRES 9 A 282 ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN SEQRES 10 A 282 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ILE SEQRES 11 A 282 ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP GLY SEQRES 12 A 282 VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG GLU SEQRES 13 A 282 PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE MET SEQRES 14 A 282 GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU SEQRES 15 A 282 GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA VAL SEQRES 16 A 282 ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 17 A 282 LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA SEQRES 18 A 282 LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SER SEQRES 19 A 282 GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP LEU SEQRES 20 A 282 ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN VAL SEQRES 21 A 282 ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO LEU SEQRES 22 A 282 LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 282 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLU SER SEQRES 2 B 282 ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SER SEQRES 3 B 282 TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA ARG SEQRES 4 B 282 ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO PHE SEQRES 5 B 282 VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU ASP SEQRES 6 B 282 LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SEQRES 7 B 282 SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN SEQRES 8 B 282 PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU TYR SEQRES 9 B 282 ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN SEQRES 10 B 282 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ILE SEQRES 11 B 282 ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP GLY SEQRES 12 B 282 VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG GLU SEQRES 13 B 282 PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE MET SEQRES 14 B 282 GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU SEQRES 15 B 282 GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA VAL SEQRES 16 B 282 ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 17 B 282 LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA SEQRES 18 B 282 LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SER SEQRES 19 B 282 GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP LEU SEQRES 20 B 282 ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN VAL SEQRES 21 B 282 ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO LEU SEQRES 22 B 282 LEU GLN GLU ILE TYR LYS ASP LEU TYR HET HIG A 1 33 HET HIG B 1 33 HETNAM HIG 2-ETHYL-5,7-DIMETHYL-3-{(1S)-5-[2-(1H-TETRAZOL-5-YL) HETNAM 2 HIG PHENYL]-2,3-DIHYDRO-1H-INDEN-1-YL}-3H-IMIDAZO[4,5- HETNAM 3 HIG B]PYRIDINE FORMUL 3 HIG 2(C26 H25 N7) FORMUL 5 HOH *93(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 GLU A 259 1 9 HELIX 4 4 GLU A 276 LYS A 301 1 26 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 ALA A 331 1 22 HELIX 7 7 SER A 342 GLY A 344 5 3 HELIX 8 8 ARG A 350 SER A 355 1 6 HELIX 9 9 PRO A 359 PHE A 363 5 5 HELIX 10 10 MET A 364 ASN A 375 1 12 HELIX 11 11 ALA A 376 GLU A 378 5 3 HELIX 12 12 ASP A 380 LEU A 393 1 14 HELIX 13 13 ASN A 402 HIS A 425 1 24 HELIX 14 14 GLN A 430 LYS A 438 1 9 HELIX 15 15 LYS A 438 GLU A 460 1 23 HELIX 16 16 GLY B 206 PHE B 226 1 21 HELIX 17 17 THR B 229 GLY B 239 1 11 HELIX 18 18 ASP B 251 MET B 256 1 6 HELIX 19 19 GLU B 276 SER B 302 1 27 HELIX 20 20 ASP B 310 SER B 332 1 23 HELIX 21 21 SER B 342 GLY B 344 5 3 HELIX 22 22 ARG B 350 SER B 355 1 6 HELIX 23 23 PRO B 359 PHE B 363 5 5 HELIX 24 24 MET B 364 ALA B 376 1 13 HELIX 25 25 ASP B 380 LEU B 393 1 14 HELIX 26 26 ASN B 402 HIS B 425 1 24 HELIX 27 27 GLN B 430 GLN B 454 1 25 HELIX 28 28 LEU B 468 TYR B 473 1 6 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O THR A 349 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 CISPEP 1 LYS A 261 ILE A 262 0 0.24 CISPEP 2 LYS A 358 PRO A 359 0 4.21 CISPEP 3 LYS B 358 PRO B 359 0 5.15 CISPEP 4 HIS B 466 PRO B 467 0 0.58 CISPEP 5 PRO B 467 LEU B 468 0 3.05 SITE 1 AC1 15 HOH A 154 ILE A 281 GLY A 284 CYS A 285 SITE 2 AC1 15 ARG A 288 SER A 289 ILE A 326 LEU A 330 SITE 3 AC1 15 LEU A 333 VAL A 339 LEU A 340 ILE A 341 SITE 4 AC1 15 SER A 342 MET A 348 MET A 364 SITE 1 AC2 11 HOH B 103 GLY B 284 CYS B 285 ARG B 288 SITE 2 AC2 11 SER B 289 ILE B 326 LEU B 340 ILE B 341 SITE 3 AC2 11 SER B 342 MET B 348 MET B 364 CRYST1 92.697 61.831 118.936 90.00 102.04 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010788 0.000000 0.002301 0.00000 SCALE2 0.000000 0.016173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008597 0.00000